Does Rallies track congressional trades in IQV?

Yes. Rallies tracks politician and congressional stock disclosures for IQV, including reported purchases, sales, dates, owners, and trade amounts when available.

Is IQV research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IQV. It does not provide personalized investment advice.

IQV (IQVIA) Stock Analysis - Politician Trades

IQVIA (IQV) is a publicly traded Healthcare sector company. As of May 21, 2026, IQV trades at $169.28 with a market cap of $28.84B and a P/E ratio of 20.97. IQV moved -0.93% today. Year to date, IQV is -26.89%; over the trailing twelve months it is +18.32%. Its 52-week range spans $134.65 to $247.05. Analyst consensus is strong buy with an average price target of $215.90. Rallies surfaces IQV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded IQV stock?

Recent politician trading activity in IQV includes disclosures from Markwayne Mullin, John Boozman, Rob Bresnahan, Rob Bresnahan, and Markwayne Mullin. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

IQV Key Metrics

Key financial metrics for IQV
Metric	Value
Price	$169.28
Market Cap	$28.84B
P/E Ratio	20.97
EPS	$8.13
Dividend Yield	0.00%
52-Week High	$247.05
52-Week Low	$134.65
Volume	1.92M
Avg Volume	0
Revenue (TTM)	$16.63B
Net Income	$1.39B
Gross Margin	0.00%

Congressional Trades in IQV

Markwayne Mullin purchase IQV on Dec 29, 2025 (amount: $50.00K) for Joint.
John Boozman sale IQV on Oct 2, 2025 (amount: $15.00K) for Joint.
Rob Bresnahan sale IQV on May 15, 2025 (amount: $15.00K).
Rob Bresnahan sale IQV on Feb 25, 2025 (amount: $15.00K).
Markwayne Mullin purchase IQV on Feb 13, 2025 (amount: $50.00K) for Joint.

Latest IQV News

IQVIA jumps as Q1 beats expectations and full-year EPS guidance rises — May 6, 2026
IQVIA rises ahead of Q1 2026 earnings report and 9 a.m. ET call — May 5, 2026
IQVIA stock jumps 5% as traders position ahead of May 5 Q1 earnings — May 4, 2026
IQVIA slides ahead of May 5 earnings as CRO demand worries linger — Apr 28, 2026
IQVIA drops nearly 6% as guidance overhang and earnings timing drive selling — Apr 23, 2026

Recent IQV Insider Trades

BOUSBIB ARI sold 36.56K (~$8.13M) on Dec 18, 2025.
Sherbet Eric sold 4.00K (~$878.80K) on Oct 29, 2025.
BOUSBIB ARI sold 800 (~$174.06K) on Oct 29, 2025.

IQV Analyst Consensus

12 analysts cover IQV: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $215.90.

Common questions about IQV

Which politicians traded IQV stock?: Recent politician trading activity in IQV includes disclosures from Markwayne Mullin, John Boozman, Rob Bresnahan, Rob Bresnahan, and Markwayne Mullin. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in IQV?: Yes. Rallies tracks politician and congressional stock disclosures for IQV, including reported purchases, sales, dates, owners, and trade amounts when available.
Is IQV research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IQV. It does not provide personalized investment advice.